Location History:
- Sunnyvale, CA (US) (2011 - 2013)
- San Ramon, CA (US) (2015)
Company Filing History:
Years Active: 2011-2015
Title: Innovator Ying Yu: Advancements in Mu Opioid Receptor Antagonism
Introduction: Ying Yu, a prominent inventor based in Sunnyvale, CA, has made significant contributions to the field of pharmaceuticals. With six patents to his name, Yu has focused primarily on compounds that interact with the mu opioid receptor, an area of research critical to developing treatments for various conditions.
Latest Patents: Among his latest patents, Ying Yu has developed 3-carboxypropyl-aminotetralin derivatives and related compounds that act as mu opioid receptor antagonists. These compounds are outlined in his patents, which detail the specific formula for these compounds and outline their potential applications. The invention further discusses pharmaceutical compositions comprising these compounds, methods of utilizing them to address conditions associated with mu opioid receptor activity, and describes the processes and intermediates useful for compound preparation.
Career Highlights: Throughout his career, Ying Yu has been affiliated with notable companies in the pharmaceutical sector, including Theravance, Inc. and Theravance Biopharma R&D IP, LLC. His work in these organizations has contributed to significant advancements in drug development and therapeutic solutions.
Collaborations: Ying Yu has worked alongside esteemed colleagues such as Pierre-Jean Colson and Daniel D. Long. Their collaborative efforts have been instrumental in the research and development of innovative pharmaceutical solutions.
Conclusion: Ying Yu's innovative work as an inventor, particularly in the area of mu opioid receptor antagonism, showcases his significant contributions to the pharmaceutical industry. His ongoing research, coupled with collaborative projects, continues to pave the way for advancements in medical treatments and therapeutic interventions.